Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Number of previous chemotherapy lines

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

No. of Regimens per Patient No. of Patients Percentage (%)
Any Regimen
 2 6 30
 3 5 25
 4 3 15
 5 2 10
 >5 4 20
Platinum-Based Combination Chemotherapy
 1 3 15
 2 8 40
 3 5 25
 4 0 0
 5 3 15
 >5 1 5